125
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Quality Control of End Results in a Danish Adjuvant Breast Cancer Multi-Center Study

, , &
Pages 711-714 | Received 14 Mar 1997, Accepted 29 Aug 1997, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Susanne Møller, Maj-Britt Jensen, Bent Ejlertsen, Karsten D. Bjerre, Martin Larsen, Hanne B. Hansen, Peer Christiansen & Henning T. Mouridsen. (2008) The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncologica 47:4, pages 506-524.
Read now
Anni R. Jensen, Hans H. Storm, Susanne Møller & Jens Overgaard. (2003) Validity and Representativity in the Danish Breast Cancer Cooperative Group. Acta Oncologica 42:3, pages 179-185.
Read now

Articles from other publishers (13)

Kristen D. Brantley, Anders Kjærsgaard, Deirdre Cronin-Fenton, Rami Yacoub, Anja S. Nielsen, Kristina L. Lauridsen, Stephen Hamilton-Dutoit & Timothy L. Lash. (2018) Stanniocalcin Expression as a Predictor of Late Breast Cancer Recurrence. Cancer Epidemiology, Biomarkers & Prevention 27:6, pages 653-659.
Crossref
Lone Winther Lietzen, Deirdre Cronin-Fenton, Peer Christiansen, Henrik Toft Sørensen & Timothy L. Lash. (2015) Autoimmune diseases and breast cancer recurrence: a Danish nationwide cohort study. Breast Cancer Research and Treatment 149:2, pages 497-504.
Crossref
David H Jones, Melisa Nestore, Sara Henophy, Julia Cousin & Alain Steve Comtois. (2014) Increased cardiovascular risk factors in breast cancer survivors identified by routine measurements of body composition, resting heart rate and arterial blood pressure. SpringerPlus 3:1.
Crossref
L.W. Lietzen, T. Ahern, P. Christiansen, A.B. Jensen, H.T. Sørensen, T.L. Lash & D.P. Cronin-Fenton. (2014) Glucocorticoid prescriptions and breast cancer recurrence: a Danish nationwide prospective cohort study. Annals of Oncology 25:12, pages 2419-2425.
Crossref
Thomas P Ahern, Timothy L Lash, Per Damkier, Peer M Christiansen & Deirdre P Cronin-Fenton. (2014) Statins and breast cancer prognosis: evidence and opportunities. The Lancet Oncology 15:10, pages e461-e468.
Crossref
Deirdre P. Cronin-Fenton, Mariann Christensen, Timothy L. Lash, Thomas P. Ahern, Lars Pedersen, Jens Peter Garne, Marianne Ewertz, Herman Autrup, Henrik T. Sørensen & Stephen Hamilton-Dutoit. (2014) Manganese Superoxide Dismutase and Breast Cancer Recurrence: A Danish Clinical Registry-Based Case-Control Study, and a Meta-Analysis. PLoS ONE 9:1, pages e87450.
Crossref
Gitte Vrelits SørensenPatricia A. GanzSteven W. ColeLars A. PedersenHenrik Toft SørensenDeirdre P. Cronin-FentonJens Peter GarnePeer M. ChristiansenTimothy L. LashThomas P. Ahern. (2013) Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study. Journal of Clinical Oncology 31:18, pages 2265-2272.
Crossref
T. P. Ahern, L. Pedersen, M. Tarp, D. P. Cronin-Fenton, J. P. Garne, R. A. Silliman, H. T. Sorensen & T. L. Lash. (2011) Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study. JNCI Journal of the National Cancer Institute 103:19, pages 1461-1468.
Crossref
T L Lash, L Pedersen, D Cronin-Fenton, T P Ahern, C L Rosenberg, K L Lunetta, R A Silliman, S Hamilton-Dutoit, J P Garne, M Ewertz & H T Sørensen. (2008) Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram. British Journal of Cancer 99:4, pages 616-621.
Crossref
P.B. Ottevanger, P Therasse, C van de Velde, J Bernier, H van Krieken, R Grol & P De Mulder. (2003) Quality assurance in clinical trials. Critical Reviews in Oncology/Hematology 47:3, pages 213-235.
Crossref
A.R. Jensena, M. Ewertz, S. Cold, H.H. Storm & J. Overgaard. (2003) Time trends and regional differences in registration, stage distribution, surgical management and survival of breast cancer in Denmark. European Journal of Cancer 39:12, pages 1783-1793.
Crossref
M. Andersson, C. Kamby, M.-B. Jensen, H. Mouridsen, B. Ejlertsen, P. Dombernowsky, C. Rose, S. Cold, M. Overgaard, J. Andersen & M. Kjær. (1999) Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer Co-operative Group DBCG 82B trial. European Journal of Cancer 35:12, pages 1659-1666.
Crossref
Marie Overgaard, Maj-Britt Jensen, Jens Overgaard, Per S Hansen, Carsten Rose, Michael Andersson, Claus Kamby, Mogens Kjaer, Carl C Gadeberg, Birgitte Bruun Rasmussen, Mogens Blichert-Toft & Henning T Mouridsen. (1999) Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. The Lancet 353:9165, pages 1641-1648.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.